PolyGone Systems Secures $4M Seed to Expand Microplastic Monitoring & Filtration Solutions
KEARNEY POINT, N.J. (February 12, 2026) PolyGone Systems, a Princeton University spinout focused on microplastic monitoring and removal, announced today that it raised a $4 million Seed round led by FYRFLY Venture Partners, with participation from Tech Council Ventures, Golden Seeds, Interstate Fusion Ventures, and angel investors Nancy and Scott Schoen. The New Jersey Innovation Evergreen Fund matched $1.65 million of the raise. In parallel, PolyGone formally launched its microplastics analysis service, offering accurate and affordable water testing for the public, private companies, and government utilities, helping them better understand exposure risks and compliance needs.
Founded in 2021, PolyGone develops a patented media and filtration system that removes 98% of toxic microplastics from water at a 90% lower cost than alternative methods. The company operates a water removal pilot for the Atlantic County Utilities Authority (ACUA) and has already signed three new commercial deployments in 2026 with plans to expand within the municipal treatment, industrial water, and food and beverage markets.
With the Seed funding, PolyGone will produce and deploy its first commercial municipal PolyPod™ systems, designed to treat up to 10 million gallons of water per day for microplastic pollutants. It will also launch a new inline PolyCartridge™ filtration system for industrial water streams.
“Microplastics are not only the most pervasive contaminant in our waters, but arguably the most misunderstood,” said Nathaniel Banks, CEO of PolyGone Systems. “This funding allows us to build the infrastructure needed to monitor microplastics across industrial, municipal, and community settings while scaling an ecosystem of filtration technologies.”
PolyGone recently finished building out a state-of-the-art microplastics analysis laboratory and manufacturing space to meet growing commercial demand and accelerate product deployment. By 2027, the company expects to triple its headcount.
As concerns grow around the endocrine-disrupting, carcinogenic, and neurotoxic effects of microplastics, PolyGone’s ability to generate proprietary datasets while achieving over 98% removal efficacy positions the company to deliver a scalable, data-driven solution. These datasets are expected to be critical in understanding the scope of microplastic contamination and in guiding the strategic deployment of filtration systems for maximum environmental and public health impact.
“PolyGone is on the path to creating a proprietary data and intelligence source that becomes critical to solving the global microplastics crisis,” said Julie Maples, Co-Founder and General Partner at FYRFLY Venture Partners. “PolyGone will be a must-have partner for water authorities that protect public health and for industrial companies that face increasing public and regulatory pressure to rein in microplastics pollution.”
About PolyGone Systems
PolyGone Systems is a New Jersey–based cleantech company developing technologies to monitor and reduce microplastic pollution in water systems. The company combines advanced microplastics analysis with deployable filtration solutions to support municipalities, industries, and communities in understanding contamination levels and implementing effective treatment strategies at scale. Learn more at www.polygonesystems.com.
Verana Health Merges with COTA
Robots at a Bristol Plant Now Package Your Variety Packs for Big Retailers
TranscendAP Partners with Rittenhouse Ventures & Tech Council Ventures to Fuel AI AP Growth
Mend and OrthoElite Partner to Redefine Perioperative Care in Arizona
Exero Medical Strengthens U.S. Expansion with $12.7M in Seed Funding
Sojo Industries Announces Strategic Collaboration Deal with Molex
Sojo Industries Awarded Patent for Sojo Flight™
Mend Welcomed Esteemed Surgeon Partners to Upgraid
Mend Quarterfinalist for Emerging Innovation at hlth
Sojo Industries Partners with Schreiber Foods on Mobile Manufacturing and Next Generation Track and Trace Platform
Vitalief CEO Recognized in NJBIZ 2024 ICON HONORS
Xevant and Ivím Health Join Forces to Bring First Full Service Corporate GLP-1 Program, Ivím at Work, to Employees
Princeton NuEnergy Raises Series A Funding to Advance Lithium-ion Battery Direct Recycling Technology
OrthoLoneStar Expands use of Mend Perioperative Solutions Across the Network
Sojo Industries Launches Sojo Shield™, a Pioneering Track and Trace Platform for Food and Beverage Brands
Xevant Embarks on Accelerated Growth with Significant Follow-on Investment from HCAP Partners and Tech Council Ventures
Princeton Identity Launches EyeAllow
Princeton Identity unveils EyeAllow, a multi-modal biometric authentication device
Vitalief Launches Innovative Float Pool Services to Address Nagging Resourcing Challenges Across Research and Clinical Trials Industry
Vitalief Announces New Clinical Trials Office and Study Activation Services
At TED2023, EpiBone CEO Dr. Nina Tandon gives an update on how far EpiBone has come in developing bone and cartilage replacements
Vitalief in collaboration with CISCRP sponsored the release of a Clinical Trials Supplement in the latest edition of USA Today
CareAlign recognized for achievements in Care Coordination and Collaboration
Xevant Announces Compliance with SOC 2 Type 2 Standards
Xevant Ranks No. 1 on the Inc. 5000 2022 List as the Fastest Growing Private Software Company in America
ReGelTec’s HYDRAFIL Technology Selected as Best Abstract Presentation at the American Society of Pain and Neuroscience Annual Meeting
Portfolio company Regenosine receives a $1.67M NIH NIAMS Phase II SBIR grant
Congratulations to portfolio company Regenosine on receiving a $1.67M NIH NIAMS Phase II SBIR grant to commercially develop their disease modifying osteoarthritis drug.